D-Panthenol (Dexpanthenol) is relevant in contexts marked by increased discomfort or tension, commonly used across conditions presenting with acute episodes. The use of D-Panthenol is generally considered relevant in various therapeutic areas.

---

Soothing Acute Skin Irritation

This therapeutic domain is applied across domains where additional symptomatic support is needed, often involving symptoms related to inflammatory or irritative states. D-Panthenol is commonly used to help with symptom clusters that may become intense or disruptive, providing support that helps ease the overall symptom burden when symptoms intensify. This therapeutic domain helps address symptom clusters that may become intense or disruptive.

“The product is relevant when supportive symptom management is appropriate.”

---

Managing Dryness and Barrier Damage

This use is applied in situations involving certain distressing symptoms, generally addressing symptoms that create noticeable physiological strain. D-Panthenol assists with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relevant for symptoms related to physical discomfort

---

Supportive Care for Minor Tissue Stress

D-Panthenol is applied in clinical settings that involve acute or unstable symptom patterns, and is commonly used when supportive symptom management is appropriate. This focuses on managing symptoms that interfere with daily comfort, providing supportive relief in scenarios that cause symptomatic discomfort.

Regulatory References

1. DailyMed Label for Dexpanthenol Ointment

Who Can and Cannot Use Д-Пантенол

The official regulatory profile for topical D-Panthenol (Dexpanthenol) is governed by a clear, limited set of population-eligibility rules, primarily focused on pre-existing sensitivity.

Populations and Restrictions

Eligibility Status	Defined Population	Regulatory Context
Contraindicated	Individuals with known hypersensitivity or allergy to Dexpanthenol or any component of the formulation.	Absolute prohibition based on regulatory labeling.
Allowed	Adults, Adolescents, and Children, including infants.	Use is generally established and permitted across all age groups for minor dermatoses.
Conditional Use	Pregnant Women	Caution is advised; use is classified as Pregnancy Category C, permitted only if the potential benefit justifies the potential risk.
Conditional Use	Nursing Mothers	Caution is advised due to insufficient data; it is not established if the substance is excreted in human milk.

The regulatory framework establishes broad eligibility for the topical product across the lifespan. No specific restrictions based on organ function, such as hepatic or renal impairment, are documented for the topical product, as regulatory restrictions are associated with systemic forms. All populations are eligible for use, provided they do not have a known allergy to the formulation.

Interactions with other medicines and products

Official regulatory documents confirm that the interaction profile for topical Dexpanthenol (Д-Пантенол) is characterized by a minimal risk of systemic drug-drug interactions. This is due to the limited absorption of the active ingredient into the bloodstream when the product is applied to the skin as directed.

Systemic and Metabolic Interactions

Interaction Type	Official Regulatory Statement
Systemic Pharmacokinetic Risk	No systemic pharmacokinetic interactions (e.g., CYP-mediated or transporter-mediated) are documented in official regulatory labels.
Exposure Modification	Regulatory documents do not list any co-administered substances that officially alter the systemic exposure (AUC or Cmax) of the medicine.
Contraindications	No medicinal products are formally listed as contraindicated due to systemic interaction risk with topical Dexpanthenol.

---

Local Administration Restrictions

The primary interaction-related constraint documented in official prescribing information is a local administration-timing restriction. Regulatory documents advise against the simultaneous application of Dexpanthenol with other topical medicinal products or preparations on the exact same skin area. This restriction is in place to prevent potential physical dilution, which could reduce the effective local concentration of either Dexpanthenol or the co-administered product. No specific interactions with food, alcohol, or herbal products are documented.

D-Panthenol, an alcohol analog of pantothenic acid (Vitamin B5), penetrates epidermal cells via passive diffusion. Inside the keratinocytes and fibroblasts, it undergoes oxidation to pantothenic acid. This acid is an essential precursor for the synthesis of Coenzyme A (CoA), a critical cofactor in numerous metabolic pathways.

CoA participates directly in the biosynthesis of structural lipids, including sphingolipids and phospholipids, which are integrated into the cellular membranes to form the bilateral lipid layer of the stratum corneum. Pantothenic acid modulates fibroblast proliferation and exerts an inhibitory effect on the nuclear factor NF-kappa B signaling pathway within keratinocytes. This specific molecular interaction influences cellular differentiation and alters the paracrine signaling that regulates the homeostasis of the skin barrier function.

Official Administration Guidelines for Д-Пантенол

The usage of Dexpanthenol (Д-Пантенол) is structured primarily around its intended route of delivery, with protocols for both topical and systemic administration.

Administration Scope	Official Requirement
Route of Administration	Primarily Topical (Cutaneous) for creams, ointments, and sprays. Intramuscular (IM) and Intravenous (IV) routes are used for specific systemic indications in approved settings.
Dosing Schedule	Topical: Apply a thin layer to the affected area, ensuring complete coverage. Dosage is determined by the extent of the area, not a fixed mass (mg). Systemic: Typically 500 mg, administered on a structured schedule (e.g., every 6 hours) during the acute phase.
Frequency Pattern	Topical: Once to several times daily (e.g., one to four times per day) or as needed, often following cleansing of the area.
Preparation Requirements	Topical: The skin must be cleaned and dried before the medicine is applied. IV: Must be diluted with compatible intravenous solutions (e.g., glucose or Lactated Ringer’s) prior to slow infusion; direct injection into the vein is not advised.
Age-Group Rules	Topical (Infants): Application for pediatric conditions (e.g., diaper rash) follows the standard topical frequency pattern, often requiring application after each diaper change.
Course Duration	The duration of treatment is short-term for acute conditions, sustained only until the skin has fully healed and epithelialization is complete.

---

Resulting Procedural Structure

Official step sequence:

• Cleanse and fully dry the skin or mucosal surface designated for application.
• Apply the prescribed dosage form (cream, ointment, or spray) to create a thin, covering layer over the entire affected area.
• Repeat the application according to the prescribed frequency, which may range from once daily to up to four times per day, or as otherwise directed by the condition.

This protocol ensures the medicine is administered directly to the site of action via the approved route, maintaining the necessary frequency until the short-term goal of tissue repair is achieved.

D-Panthenol: Recent Clinical Evidence

Overview of Clinical Applications

D-Panthenol (dexpanthenol) is the alcohol analog of pantothenic acid (Vitamin B5). It is widely incorporated into topical products and is classified as a provitamin due to its conversion to pantothenic acid in the skin. Research on D-Panthenol primarily focuses on its influence on skin barrier function, hydration, and wound healing.

Studies investigating D-Panthenol often involve measuring transepidermal water loss (TEWL), a key indicator of skin barrier integrity. In healthy skin models, topical application of D-Panthenol has been associated with a notable decrease in TEWL, suggesting a strengthening of the skin's barrier against external factors and moisture loss.

---

Key Research Findings

Area of Research	Study Focus	Observed Outcomes (Neutral Summary)
Skin Barrier	Topical formulations applied to compromised skin.	Research indicated that D-Panthenol may support the recovery of barrier function following chemical or physical irritation.
Wound Healing	Post-surgical or minor skin lesions.	Studies evaluated whether the agent influenced cell migration and proliferation, processes central to the skin regeneration phase.
Hydration	Assessment of skin moisture content.	Research observed an increase in skin hydration in trial participants using D-Panthenol formulations compared to control groups.

---

Safety and Tolerability

Clinical trials and extensive dermatological use suggest that D-Panthenol is generally well-tolerated in topical applications. Adverse reactions are infrequent and typically limited to mild, localized skin irritation, which is often attributed to other inactive ingredients in the vehicle formulation. Research indicates a low potential for sensitization.

Common questions about Д-Пантенол (FAQ)

---

Q: Can Д-Пантенол help with minor scrapes or cuts?

A: Regulatory documents indicate that the active ingredient, dexpanthenol, is officially used for promoting the healing and epithelialization (new tissue formation) of minor wounds and minor skin lesions. This generally covers superficial skin damage like small abrasions.

---

Q: Is Д-Пантенол safe to use on a baby's diaper rash?

A: Official information confirms that topical dexpanthenol is permitted for use in pediatric populations, including infants. For conditions like diaper rash, regulatory information specifies application can follow the required frequency pattern. Full usage instructions are located in the product information leaflet.

---

Q: Can Д-Пантенол be used on the face for general moisturizing?

A: Dexpanthenol is a dermatoprotective agent that enhances epidermal hydration and supports the skin barrier, which are properties common to moisturizers. However, its primary classification is as a substance intended to support the repair and healing of damaged skin.

---

Q: What kind of allergic reactions, if any, are possible with Д-Пантенол?

A: The official safety profile reports that allergic reactions, including hypersensitivity and allergic contact dermatitis, are classified as rare adverse effects. These reactions may involve symptoms such as pruritus (itching), erythema (redness), or urticaria (hives).

---

Q: Can I use Д-Пантенол at the same time as a moisturizer that contains retinol?

A: Official guidelines advise against the simultaneous application of dexpanthenol with other topical products or preparations on the exact same skin area. This restriction is intended to prevent physical dilution, which could reduce the effective local concentration of either product.

---

Q: Is Д-Пантенол considered safe for use during pregnancy?

A: Official regulatory sources generally permit the use of topical dexpanthenol during pregnancy and breastfeeding, based on very low systemic absorption. Its regulatory classification often notes that use is permitted when the potential benefit is determined to justify any potential risk.

---

Q: How long after a wound is closed can I keep applying Д-Пантенол?

A: Regulatory documents define the treatment duration as short-term. Application should continue only until the skin has fully healed and epithelialization, which is the formation of new tissue over the wound, is complete.

---

Q: What percentage of the active ingredient is typically found in the consumer products?

A: The active concentration can vary between specific brands and forms. However, clinical research and studies frequently investigate and utilize formulations containing a concentration of the active ingredient, dexpanthenol, at around 5%.

---

Q: Are there specific preservatives in some Д-Пантенол products that people should be aware of?

A: The medicine is strictly contraindicated if a person has a known allergy not only to the active substance (Dexpanthenol) but also to any of the product's excipients, which include preservatives. The full ingredient list should be reviewed if there are known sensitivities to other substances.

---

Q: Is Д-Пантенол considered an occlusive, a humectant, or an emollient?

A: Dexpanthenol itself is classified as a hygroscopic substance, meaning it actively attracts and holds moisture, giving it humectant properties. It is often formulated into dermatoprotective products that help support the skin's natural barrier.

---

Q: Does Д-Пантенол require a prescription?

A: Topical dexpanthenol is widely classified and available as an over-the-counter (OTC) medicine in many countries. Its classification as a dermatoprotective agent generally allows it to be purchased without a prescription.

---

Q: Does Д-Пантенол have any pain-relieving effects?

A: The primary classification of topical dexpanthenol is as a tissue regeneration stimulant. While it is not an analgesic, some regulatory sources note its use in products to relieve associated symptoms like itching in certain dermatological conditions.

---

Q: Can Д-Пантенол interfere with the absorption of other topicals applied immediately after?

A: Regulatory documents explicitly advise against simultaneous application of dexpanthenol with other topical medicines on the same area. This is intended to prevent physical dilution, which could interfere with the local concentration and potentially reduce the effectiveness of either product.

---

Q: What kind of injuries or burns is Д-Пантенол not effective for?

A: The official indication for the product is specifically limited to minor wounds and minor burns. It is not indicated for treating deep, extensive, or severe injuries or burns, such as those that require immediate medical attention.

---

Q: What are the benefits of using Д-Пантенол on minor burns from cooking?

A: Official regulatory monographs support the traditional use of dexpanthenol for promoting the epithelialization and healing of minor burns. This therapeutic action is relevant for small, superficial burns often sustained from cooking.

---

Q: How does temperature affect the stability or efficacy of the cream formulation?

A: Official storage guidelines require that topical forms of the product be stored at or below 30 C (86 F). The container must also be kept tightly closed and protected from direct sunlight to maintain the product's stability and effectiveness over time.

How to Store and Dispose of D-Panthenol

Storage and disposal of D-Panthenol (Dexpanthenol) must strictly adhere to the conditions mandated in official regulatory labeling to ensure product stability and safety.

---

Official Storage Requirements

Storage Domain	Regulatory Condition
Temperature Range	Store topical forms at or below 30 C (86 F). Injectable solutions require a narrower 20 C to 25 C range.
Environmental Protection	Keep the container tightly closed and store the product in a dry place, protected from direct sunlight.
Stability After Opening	Stability for some cream forms is limited to one month after opening. Unused portions of the injectable solution must be discarded immediately.
Child Safety	The product must be stored out of the sight and reach of children.

---

Disposal Instructions

Disposal must be executed in accordance with applicable federal, state, and local regulations. The product should not be flushed down the toilet or allowed to enter drains, waterways, or soil.